Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

MEDRELEAF CORP > LEAF for sale
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Nacksackattackon May 02, 2018 7:09pm
251 Views
Post# 27973375

RE:LEAF for sale

RE:LEAF for sale
Bigdogmoney wrote: This could be an easy $21 to $30 surge in SP once buyers NR is released...I am locked and loaded

I still say $30 equivalent is the buyout price.  And I also think a big Pharma company, a big brewer or a tobacco company buys the whole thing out. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities